Decentralised clinical trials

The Covid-19 pandemic has led to improvements in clinical trial processes and a more technology-driven approach, a new report from Medidata has revealed. The report ‘European Industry Research Report: The Future of Clinical Trials’ includes insights from 400 clinical trial executives across the United Kingdom, France, Germany and Switzerland. The findings from the research indicate […]

Clinical trial support organisation Medical Research Network (MRN) has won a Queen’s Award for Enterprise for International Trade for its work in helping enhance the delivery of clinical trials through decentralisation technology.  The Queen’s Awards   Established in 1965, The Queen’s Awards for Enterprise are the most prestigious business awards in the UK. They celebrate the success […]

 A fully integrated patient-centric platform has been launched to help optimise the management of hybrid and decentralised clinical trials (DCT).    The platform   The platform, developed by Kayentis, has been designed to help clinical trials providers overcome the logistical hurdles faced when bringing trials to patients’ homes, whilst also improving how patients and sites use DCT […]

“The message was clear from industry leaders this year whether on social media or conferences: today’s clinical trials need decentralised solutions”, says Temitope Keyes, Executive Director Business Development at encapsia, commenting on the decentralised clinical trial (DCT) event horizon.  Clinical trials are now more complex than ever, and sites and patients can (and will) be […]